Results 121 to 130 of about 666,121 (300)
A worldwide decrease in the incidence of gastric cancer and its most common form, adenocarcinoma, has long been observed. Helicobacter pylori (H. pylori) is a causative carcinogen for gastric adenocarcinoma. Triple and quadruple regimens for H.
Y.O. Protas +2 more
doaj +1 more source
Clinical Translation of Patient‐Derived Organoids: Perspectives for Personalized Therapy in Cancer
ABSTRACT Patient‐derived organoids (PDO) are accelerating precision medicine. These biological platforms allow for the autologous in vitro expansion of material from cancer patients in a considerably short period of time. These three‐dimensional models can faithfully recapitulate aspects of tissue heterogeneity, architecture, and relevant cellular ...
Haiyan Yue +6 more
wiley +1 more source
BackgroundVery well-differentiated gastric adenocarcinoma (VWDA) is a rare variant of gastric cancer, for which the diagnostic criteria and clinical behavior are not fully established.
Jiaqi Chen +3 more
doaj +1 more source
Adenocarcinoma arising from a gastric duplication cyst: a case report and literature review
Maheeba Abdulla Mohamed Abdulla,1 Mahmood Al Saeed,1 Safa Ameer Alshaikh,2 Umesh J Nabar3 1Department of Internal Medicine, 2Department of Pathology, 3Department of Radiology, Salmaniya Medical Complex, Manama, The Kingdom of Bahrain Introduction ...
Abdulla MA +3 more
core
Improved survival in gastric adenocarcinoma
Despite advances in surgical treatment and systemic therapy during recent decades, the prognosis of gastric adenocarcinoma remains poor. This thesis aims to identify factors that may contribute to improving long-term survival in patients with gastric ...
Wilhelm Leijonmarck (18660994)
core +1 more source
Activity of Low Dose Nivolumab in Patients With Advanced Squamous Cell Carcinomas and Other Cancers
ABSTRACT Immune checkpoint inhibitors such as anti–PD‐1 antibodies are essential in cancer therapy. Emerging data suggest that lower doses may be effective and more economical, though further evidence is needed. We conducted a retrospective study at Centre Léon Bérard to assess the efficacy and safety of low‐dose nivolumab (20 mg every 3 weeks) in ...
Thibault Gauduchon +16 more
wiley +1 more source
A case of gastric adenocarcinoma with pyloric gland-type infiltrating submucosa
Background The development of immunohistochemical staining has revealed that gastric adenocarcinoma with the gastric phenotype can be divided into the foveolar, fundic gland, and pyloric gland phenotypes.
Kaiho Hirata +9 more
doaj +1 more source
ABSTRACT Long‐term survival data for patients with locally advanced gastro‐esophageal adenocarcinoma (GEA) treated with neoadjuvant chemoimmunotherapy are lacking. We describe the long‐term disease‐free survival (DFS) and overall survival (OS) outcomes of such patients treated with a novel neoadjuvant chemoimmunotherapy regimen, aDCF (avelumab with ...
Thierry Alcindor +8 more
wiley +1 more source
This study aimed to identify biomolecular differences between benign gastric tissues (gastritis/intestinal metaplasia) and gastric adenocarcinoma and to evaluate the diagnostic power of Raman spectroscopy-based machine learning in gastric adenocarcinoma.
Alex Noh +7 more
doaj +1 more source
Chemotherapy for Esophageal Adenocarcinoma
Esophageal and esophagogastric junction adenocarcinoma is a distinct entity from esophageal squamous cell carcinoma with respect to etiology and biology despite sharing the same anatomical location. While most international treatment guidelines recommend
Lam, KO +3 more
core +1 more source

